Average Co-Inventor Count = 7.80
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (42 from 2,076 patents)
2. 3-dimensional Pharmaceuticals, Inc. (2 from 76 patents)
3. Bristol-myers Squibb Compnay (1 from 3,681 patents)
4. Janssen Sciences Ireland Unlimited Company (1 from 60 patents)
46 patents:
1. 12134636 - Immunoglobulins and uses thereof
2. 11780900 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
3. 11767354 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
4. 11732019 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
5. 11591379 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
6. 11401315 - Immunoglobulins and uses thereof
7. 11230526 - Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors
8. 10968265 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
9. 10968264 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
10. 10961293 - Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
11. 10875902 - Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
12. 10858413 - Immunoglobulins and uses thereof
13. 10787495 - Immunoglobulins and uses thereof
14. 10653673 - Substituted imidazoles as N-type calcium channel blockers
15. 10640544 - Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors